Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and rationale of the Engage-HF study: the impact of a gamified engagement toolkit on participation and engagement in a heart failure registry.
Shakoor A, Mohansingh C, El Osrouti A, Borleffs JWC, van Houwelingen GK, van de Swaluw JEC, van Kimmenade R, den Besten M, Pisters R, van Ofwegen-Hanekamp CEE, Koudstaal S, Handoko LM, Asselbergs FW, van Veghel D, van Wijk SS, van der Boon RMA, Brugts JJ, Schaap J. Shakoor A, et al. Among authors: van houwelingen gk. Eur Heart J Digit Health. 2024 Jul 15;5(5):643-650. doi: 10.1093/ehjdh/ztae052. eCollection 2024 Sep. Eur Heart J Digit Health. 2024. PMID: 39318682 Free PMC article.
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.
Van't Hof AW, Ten Berg J, Heestermans T, Dill T, Funck RC, van Werkum W, Dambrink JH, Suryapranata H, van Houwelingen G, Ottervanger JP, Stella P, Giannitsis E, Hamm C; Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Van't Hof AW, et al. Among authors: van werkum w, van houwelingen g. Lancet. 2008 Aug 16;372(9638):537-46. doi: 10.1016/S0140-6736(08)61235-0. Lancet. 2008. PMID: 18707985 Clinical Trial.
Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction.
Heestermans AA, Van Werkum JW, Hamm C, Dill T, Gosselink AT, De Boer MJ, Van Houwelingen G, Hoorntje JC, Koopmans PC, Ten Berg JM, Van 't Hof AW. Heestermans AA, et al. Among authors: van t hof aw, van werkum jw, van houwelingen g. J Thromb Haemost. 2009 Oct;7(10):1612-8. doi: 10.1111/j.1538-7836.2009.03573.x. Epub 2009 Aug 11. J Thromb Haemost. 2009. PMID: 19682233 Free article. Clinical Trial.
Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.
ten Berg JM, van 't Hof AW, Dill T, Heestermans T, van Werkum JW, Mosterd A, van Houwelingen G, Koopmans PC, Stella PR, Boersma E, Hamm C; On-TIME 2 Study Group. ten Berg JM, et al. Among authors: van t hof aw, van werkum jw, van houwelingen g. J Am Coll Cardiol. 2010 Jun 1;55(22):2446-55. doi: 10.1016/j.jacc.2009.11.091. J Am Coll Cardiol. 2010. PMID: 20510211 Free article. Clinical Trial.
The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy.
Heestermans T, van 't Hof AW, ten Berg JM, van Werkum JW, Boersma E, Mosterd A, Stella PR, van Zoelen AB, Gosselink AT, Kochman W, Dill T, Koopmans PC, van Houwelingen G, Zijlstra F, Hamm C. Heestermans T, et al. Among authors: van zoelen ab, van t hof aw, van werkum jw, van houwelingen g. Am Heart J. 2010 Dec;160(6):1079-84. doi: 10.1016/j.ahj.2010.08.039. Am Heart J. 2010. PMID: 21146661 Clinical Trial.
Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: correlates of reperfusion before primary PCI.
Heestermans T, Suryapranata H, ten Berg JM, Mosterd A, Gosselink AT, Kochman W, Dill T, van Houwelingen G, Kolkman E, van Werkum JW, Zijlstra F, Hamm C, van 't Hof AW. Heestermans T, et al. Among authors: van t hof aw, van houwelingen g, van werkum jw. J Electrocardiol. 2011 Jan-Feb;44(1):42-8. doi: 10.1016/j.jelectrocard.2010.09.010. J Electrocardiol. 2011. PMID: 21168000 Clinical Trial.
The impact of age on effects of pre-hospital initiation of high bolus dose of tirofiban before primary angioplasty for ST-elevation myocardial infarction.
Hermanides RS, van Houwelingen G, Ottervanger JP, de Boer MJ, Dill T, Hamm C, Stella PR, Boersma E, ten Berg JM, van 't Hof AW; On-TIME 2 trial investigators. Hermanides RS, et al. Among authors: van t hof aw, van houwelingen g. Cardiovasc Drugs Ther. 2011 Aug;25(4):323-30. doi: 10.1007/s10557-011-6314-8. Cardiovasc Drugs Ther. 2011. PMID: 21744314 Clinical Trial.
Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay.
Heestermans T, de Boer MJ, van Werkum JW, Mosterd A, Gosselink AT, Dambrink JH, van Houwelingen G, Koopmans P, Hamm C, Zijlstra F, ten Berg JM, van 't Hof AW. Heestermans T, et al. Among authors: van t hof aw, van werkum jw, van houwelingen g. EuroIntervention. 2011 Aug;7(4):442-8. doi: 10.4244/EIJV7I4A73. EuroIntervention. 2011. PMID: 21764662 Free article. Clinical Trial.
Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.
Hermanides RS, Ottervanger JP, ten Berg JM, Gosselink AT, van Houwelingen G, Dambrink JH, Stella PR, Hamm C, van 't Hof AW; On-TIME 2 Trial Investigators. Hermanides RS, et al. Among authors: van t hof aw, van houwelingen g. J Invasive Cardiol. 2012 Mar;24(3):84-9. J Invasive Cardiol. 2012. PMID: 22388296 Free article. Clinical Trial.
40 results